New Paper Published: Plasma S100β is a Predictor for Pathology and Cognitive Decline in Alzheimer’s Disease

This study highlights plasma S100β as a promising non-invasive biomarker for early detection and progression monitoring of Alzheimer’s disease. Given its strong association with cognitive decline and AD pathology, S100β could serve as a valuable diagnostic tool, addressing the urgent need for accessible biomarkers to guide early interventions and treatment strategies.

View Publication

Recent Posts

Hady presents at the Trainee Research Day

Hady presented a poster on anti-amyloid antibodies and their effects on blood-brain barrier integrity at the College of Medicine Trainee Research Day. This work represents a new and timely research direction in the lab that aligns with the development of novel disease-modifying antibody therapeutics for Alzheimer’s disease.

Read More »
March 23, 2026

BHL Team takes the Lexington Polar Plunge

We participated in the Polar Plunge to support Special Olympics Kentucky. Despite the cold conditions (outside temperature: 12°F; water temperature: 30°F), we joined other community participants to help raise funds and awareness for athletes with intellectual disabilities. The event provided an opportunity for the lab to contribute to a local

Read More »
February 7, 2026

BHL Holiday Party

The BHL Annual Holiday Party brought the team together to mark the end of the year. We shared food, spent time together, and played a white elephant gift exchange. It was a nice opportunity to connect outside the lab!

Read More »
December 20, 2025